6505--Fluticasone/Salmeterol Inh Powder
Veterans Affairs, Department of · VETERANS AFFAIRS, DEPARTMENT OF
This notice is not accepting responses (deadline was Mar 8, 2026, 8:00 PM EDT).
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- Mar 8, 2026, 8:00 PM EDT
- Posted
- Feb 1, 2026
- Solicitation
- 36E79726R0009
- Set-aside
- None listed
- Place of performance
- Hines
- Contracting office
- NAC PHARMACEUTICALS (36E797) · HINES · IL
- Source
- SAM.gov · updated May 9, 2026
Description
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0009 for an unrestricted procurement for Fluticasone/Salmeterol Inhaler, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name and strength of the drug being supplied as it will appear on the label. Offerors shall also provide a unique 11-digit NDC number for all items offered; the NDC number must be specific to the offering company and to the drug being supplied. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All inhalers must be individually boxed and must contain the bar code. (e.g., inhalers etc.) All bottles must be compatible with automated dispensing units (Baxter ATC Canisters, Optifill, etc. Glass bottles are not acceptable for the product type offered. Items are identified in the Schedule of Supplies and in Attachment C. By submitting an offer in response to this solicitation, the offeror certifies that all offered products have passed any required stability testing for all proposed package sizes Solicitation # 36E79726R0009 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 23, 2026, with a tentative closing date of March 9, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar. Questions can be e-mailed to Youlanda.Duggar@va.gov. The estimated annual requirements are as follows: Line Item 1: FLUTICASONE 100MCG/SALMETEROL 50MCG INHL,ORAL POWDER 60 (Doses), 30 Day Supply Total EST Annual Usage (BT): 317,019 Canister Line Item 2: FLUTICASONE 250MCG/SALMETEROL 50MCG INHL,ORAL,POWDER 60 (Doses), 30 Day Supply Total EST Annual Usage (BT): 1,479,360 Canister Line Item 3: FLUTICASONE 500MCG/SALMETEROL 50MCG INHL,ORAL,POWDER 60 (Doses), 30 Day Supply Total EST Annual Usage (BT): 504,192 Canister
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$36,321
Middle of the pack for similar past awards
Most similar awards fall between $8,499 and $203,138
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1MCKESSON CORPORATION2023 awards$11.98B
- 2BAVARIAN NORDIC A/S1 award$1.17B
- 3EMERGENT BIOSOLUTIONS CANADA INC2 awards$624.99M
- 4CHARTWELL RX LLC3 awards$254.44M
- 5ALVOGEN, INC.1 award$227.68M
- 6MERCK SHARP & DOHME LLC31 awards$157.47M
- 7GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC.1 award$130.32M
- 8ELUSYS THERAPEUTICS INC1 award$124.52M
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID 7ab65a5fb9f74b9c94dcabc522df2e29.